{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:45:48Z","timestamp":1787867148392,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council Taiwan","doi-asserted-by":"publisher","award":["NSC-101-2320-B-033-001 and 003"],"award-info":[{"award-number":["NSC-101-2320-B-033-001 and 003"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12885-016-2181-9","type":"journal-article","created":{"date-parts":[[2016,2,22]],"date-time":"2016-02-22T08:40:41Z","timestamp":1456130441000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["METCAM\/MUC18 is a novel tumor and metastasis suppressor for the human ovarian cancer SKOV3 cells"],"prefix":"10.1186","volume":"16","author":[{"given":"Guang-Jer","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-fang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,22]]},"reference":[{"issue":"1","key":"2181_CR1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics 2014. CA Cancer J Clin. 2014;64(1):9\u201329.","journal-title":"CA Cancer J Clin"},{"key":"2181_CR2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1056\/NEJMcp0901926","volume":"361","author":"DL Clarke-Pearson","year":"2009","unstructured":"Clarke-Pearson DL. Screening for ovarian cancer. N Engl J Med. 2009;361:170\u20137.","journal-title":"N Engl J Med"},{"key":"2181_CR3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2559.2005.02194.x","volume":"47","author":"WG McCluggage","year":"2005","unstructured":"McCluggage WG, Wilkinson N. Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features. Histopathology. 2005;47:231\u201347.","journal-title":"Histopathology"},{"issue":"supplement 10","key":"2181_CR4","doi-asserted-by":"crossref","first-page":"x7","DOI":"10.1093\/annonc\/mdt462","volume":"24","author":"W Wei","year":"2013","unstructured":"Wei W, Dizon D, Vathipadiekal V, Birrer MJ. Ovarian cancer: genomic analysis. Ann Oncol. 2013;24(supplement 10):x7\u201315.","journal-title":"Ann. Oncol."},{"key":"2181_CR5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ygyno.2013.11.030","volume":"132","author":"U Menon","year":"2014","unstructured":"Menon U, Griffin M, Gentry-Maharaj A. Ovarian cancer screening-current status, future directions. Gynecol Oncol. 2014;132:490\u20135.","journal-title":"Gynecol Oncol"},{"key":"2181_CR6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1757-2215-7-60","volume":"7","author":"F Jacob","year":"2014","unstructured":"Jacob F, Nixdorf S, Hacker NF, Heinzelmann-Schwarz VA. Reliable in vitro studies require appropriate ovarian cancer cell lines. J Ovarian Res. 2014;7:60 (10 pages).","journal-title":"J Ovarian Res"},{"key":"2181_CR7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Harahan","year":"2011","unstructured":"Harahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"2181_CR8","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nrc1276","volume":"4","author":"U Cavallaro","year":"2005","unstructured":"Cavallaro U, Christofori G. Cell adhesion and signaling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer. 2005;4:118\u201332.","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"2181_CR9","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/IGC.0b013e3181a8331f","volume":"19","author":"S Bellone","year":"2009","unstructured":"Bellone S, Siegel ER, Cocco E, Cargnelutti M, Silasi DA, Azodi M, et al. Over-expression of epithelial cell adhesion molecule in primary, metastatic, and recurrent\/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy. Int J Gynecol Cancer. 2009;19(5):860\u20136.","journal-title":"Int. J. Gynecol. Cancer"},{"key":"2181_CR10","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1074\/jbc.M312372200","volume":"279","author":"A Rump","year":"2004","unstructured":"Rump A, Morikawa Y, Tanaka M, Minami S, Umesaki N, Takeuchi M, et al. Binding of ovarian cancer antigen CA125\/MUC16 to mesothelin mediates cell adhesion. J Biol Chem. 2004;279:9190\u20138.","journal-title":"J Biol Chem"},{"key":"2181_CR11","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/gyno.1999.5388","volume":"73","author":"T Strobel","year":"2004","unstructured":"Strobel T, Cannistra SA. \u03b21-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro. Gynecol Oncol. 2004;73:362\u20137.","journal-title":"Gynecol. Oncol."},{"key":"2181_CR12","doi-asserted-by":"crossref","first-page":"11961","DOI":"10.1074\/jbc.M411985200","volume":"280","author":"LYW Bourguignon","year":"2005","unstructured":"Bourguignon LYW, Gilad E, Rothman K, Peyrollier K. Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1\/estrogen receptor transcription activation, and ovarian cancer progression. J Biol Chem. 2005;280:11961\u201372.","journal-title":"J Biol Chem"},{"key":"2181_CR13","first-page":"375","volume":"13","author":"NI Euer","year":"2005","unstructured":"Euer NI, Kaul S, Deissler H, Mobus VJ, Zeillinger R, Weidle UH. Identification of L1CAM, Jagged2, and neuromedin U as ovarian cancer-associated antigens. Oncol Rep. 2005;13:375\u201387.","journal-title":"Oncol Rep"},{"key":"2181_CR14","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.humpath.2004.09.014","volume":"35","author":"T Imai","year":"2004","unstructured":"Imai T, Horiuchi A, Shiozawa T, Osada R, Kikuchi N, Ohira S. Elevated expression of E-cadherin and alpha-, beta-, and gamma-catenins in metastatic lesions compared with primary epithelial ovarian carcinomas. Human Pathol. 2004;35:1469\u201376.","journal-title":"Human Pathol"},{"key":"2181_CR15","doi-asserted-by":"crossref","first-page":"26233","DOI":"10.1074\/jbc.M502003200","volume":"280","author":"T D\u2019Souza","year":"2005","unstructured":"D\u2019Souza T, Agarwal R, Morin PJ. Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein kinase regulates tight junction barrier function in ovarian cancer cells. J Biol Chem. 2005;280:26233\u201340.","journal-title":"J Biol Chem"},{"issue":"5","key":"2181_CR16","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/IGC.0b013e3182929056","volume":"23","author":"K Pietzner","year":"2013","unstructured":"Pietzner K, Woopen H, Richter R, Joens T, Braicu EI, Dimitrova D, et al. Expression of EpCAM in paired tumor samples of patients with primary and recurrent serous ovarian cancer. Int J Gynecol Cancer. 2013;23(5):797\u2013802.","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"2181_CR17","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/ijc.22082","volume":"119","author":"D Aldovini","year":"2006","unstructured":"Aldovini D, Demichelis F, Doglioni C, Di Vizio D, Galligioni E, Brugnara S, et al. M-CAM expression as marker of poor prognosis in epithelial ovarian cancer. Int J Cancer. 2006;119(8):1920\u20136.","journal-title":"Int J Cancer"},{"key":"2181_CR18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.tjog.2014.03.003","volume":"53","author":"GJ Wu","year":"2014","unstructured":"Wu GJ, Dickerson EB. Frequent and increased expression of human METCAM\/MUC18 in cancer tissues and metastatic lesions associates with the clinical progression of human ovarian carcinoma. Taiwan J Obstet Gynecol. 2014;53:509\u201317.","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"2181_CR19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2174\/1389202054750211","volume":"6","author":"GJ Wu","year":"2005","unstructured":"Wu GJ. METCAM\/MUC18 expression and cancer metastasis. Curr Genomics. 2005;6:333\u201349.","journal-title":"Curr. Genomics"},{"key":"2181_CR20","doi-asserted-by":"crossref","first-page":"9891","DOI":"10.1073\/pnas.86.24.9891","volume":"86","author":"JM Lehmann","year":"1989","unstructured":"Lehmann JM, Reithmuller G, Johnson JP. MUC18, a marker of tumor progression in human melanoma. Proc Natl Acad Sci U S A. 1989;86:9891\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2181_CR21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<4::AID-PATH332>3.0.CO;2-P","volume":"189","author":"IM Shih","year":"1999","unstructured":"Shih IM. The role of CD146 (Mel-CAM) in biology and pathology. J Pathol. 1999;189:4\u201311.","journal-title":"J Pathol"},{"key":"2181_CR22","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.juro.2010.11.052","volume":"185","author":"GJ Wu","year":"2011","unstructured":"Wu GJ, Wu MWH, Liu Y. Enforced expression of human METCAM\/MUC18 increases the tumorigenesis of human prostate cancer cells in nude mice. J Urol. 2011;185:1504\u201312.","journal-title":"J Urol"},{"key":"2181_CR23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2407-11-113","volume":"11","author":"G Zeng","year":"2011","unstructured":"Zeng G, Cai S, Wu GJ. Up-regulation of METCAM\/MUC18 promotes motility, invasiveness and tumorigenesis of human breast cancer cells. BMC Cancer. 2011;11:113. doi: 10.1186\/1471-2407-11-113 .","journal-title":"BMC Cancer"},{"key":"2181_CR24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.gene.2011.10.024","volume":"492","author":"G Zeng","year":"2012","unstructured":"Zeng G, Cai S, Liu Y, Wu GJ. METCAM\/MUC18 augments promotes migration, invasion and tumorigenicity of human breast cancer SK-BR-3 Cells. Gene. 2012;492:229\u201338.","journal-title":"Gene"},{"issue":"11","key":"2181_CR25","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1158\/1541-7786.MCR-07-2200","volume":"6","author":"GJ Wu","year":"2008","unstructured":"Wu GJ, Fu P, Wang S-W, Wu MWH. Enforced expression of MCAM\/MUC18 increased in vitro motility and invasiveness and in vivo metastasis of two mouse melanoma K1735 Sublines in a syngeneic mouse model. Mol Cancer Res. 2008;6(11):1666\u201377.","journal-title":"Mol Cancer Res"},{"key":"2181_CR26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.gene.2003.11.018","volume":"327","author":"GJ Wu","year":"2004","unstructured":"Wu GJ, Qiong P, Fu P, Wang S-W, Chiang CF, Dillehay DL, et al. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells. Gene. 2004;327:201\u201313.","journal-title":"Gene"},{"issue":"4","key":"2181_CR27","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1073\/pnas.1111053108","volume":"109","author":"Q Zeng","year":"2012","unstructured":"Zeng Q, Li W, Lu D, Wu Z, Duan H, Luo Y, et al. CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer. Proc Natl Acad Sci U S A. 2012;109(4):1127\u201332.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2181_CR28","first-page":"745","volume":"151","author":"IM Shih","year":"1997","unstructured":"Shih IM, Hsu M-Y, Palazzo JP, Herlyn M. The cell-cell adhesion receptor MEL-CAM acts as a tumor suppressor in breast carcinoma. Am J Pathol. 1997;151:745\u201351.","journal-title":"Am J Pathol"},{"key":"2181_CR29","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s13277-012-0417-0","volume":"33","author":"Z Wu","year":"2012","unstructured":"Wu Z, Wu Z, Li J, Yang X, Wang Y, Yu Y, et al. MCAM is a novel metastasis marker and regulates spreading, apoptosis and invasion of ovarian cancer cells. Tumor Biol. 2012;33:1619\u201328.","journal-title":"Tumor Biol"},{"key":"2181_CR30","first-page":"510","volume":"71","author":"N Auersperg","year":"1994","unstructured":"Auersperg N, Maines-Banders SL, Dyck HG, Kruk PA. Characterization of cultured human ovarian surface epithelial cells (IOSE): phenotypic plasticity and premalignant changes. Lab Invest. 1994;71:510\u20138.","journal-title":"Lab Invest"},{"key":"2181_CR31","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/1097-0142(19890115)63:2<280::AID-CNCR2820630213>3.0.CO;2-N","volume":"63","author":"KR Geisinger","year":"1989","unstructured":"Geisinger KR, Kute TE, Pettenati MJ, Welander CE, Dennard Y, Collins LA, et al. Characterization of a human ovarian carcinoma cell line, BG-1, with estrogen and progesterone receptors. Cancer. 1989;63:280\u20138.","journal-title":"Cancer"},{"key":"2181_CR32","first-page":"3668","volume":"45","author":"RN Buick","year":"1985","unstructured":"Buick RN, Pullano R, Trent JM. Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res. 1985;45:3668\u201376.","journal-title":"Cancer Res"},{"key":"2181_CR33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0020-711X(85)90211-3","volume":"17","author":"GJ Wu","year":"1985","unstructured":"Wu GJ, Lu SY, Lowe LL, Kinkade Jr JM. Identification of lactate dehydrogenase-M polypeptide translated in vitro from human and mouse tumor cell poly(A)-containing mRNA. Int J Biochem. 1985;17:355\u201363.","journal-title":"Int J Biochem"},{"key":"2181_CR34","isbn-type":"print","first-page":"229","volume-title":"Research on Melanoma: a glimpse into current directions and future trends","author":"GJ Wu","year":"2011","unstructured":"Wu GJ. Chapter 11: Dual roles of the melanoma CAM (MelCAM\/METCAM) in malignant progression of melanoma. In: Murph M, editor. Research on Melanoma: a glimpse into current directions and future trends. Rijeka: InTech-Open Access Publisher, University Campus STeP Ri; 2011. p. 229\u201342. http:\/\/www.intechopen.com\/books\/medicine. ISBN 978-953-307-293-7.","ISBN":"https:\/\/id.crossref.org\/isbn\/9789533072937"},{"issue":"1","key":"2181_CR35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7314\/APJCP.2014.15.1.245","volume":"15","author":"JC Lin","year":"2014","unstructured":"Lin JC, Chiang CF, Wang SW, Wang WY, Kwan PC, Wu GJ. Significance and expression of human METCAM\/MUC18 in nasopharyngeal carcinoma (NPC) and metastatic lesions. Asian Pac J Cancer Prev. 2014;15(1):245\u201352.","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"2181_CR36","volume-title":"The putative role of human METCAM\/MUC18 in modulating the development and progression of nasopharyngeal carcinoma","author":"YC Liu","year":"2014","unstructured":"Liu YC. The putative role of human METCAM\/MUC18 in modulating the development and progression of nasopharyngeal carcinoma. Chung Li: M.S. thesis under the supervision of Dr. Guang-Jer Wu, Department of Bioscience Technology, Chung Yuan Christian University; 2014. http:\/\/www.lib.cycu.edu.tw\/thesis ."},{"key":"2181_CR37","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/path.1443","volume":"201","author":"Q Li","year":"2003","unstructured":"Li Q, Yu Y, Bischoff J, Milliken JB, Olsen BR. Differential expression of CD146 in tissues and endothelial cells derived from infantile haemangioma and normal human skin. J Path. 2003;201:296\u2013302.","journal-title":"J Path"},{"key":"2181_CR38","first-page":"853797","volume":"2012","author":"GJ Wu","year":"2012","unstructured":"Wu GJ. Dual roles of METCAM in the in the progression of different cancers. J Oncol. 2012;2012:853797. doi: 10.1155\/2012\/853797 .","journal-title":"J Oncol"},{"key":"2181_CR39","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1158\/0008-5472.CAN-09-3592","volume":"70","author":"LM Vecchiarelli-Federico","year":"2010","unstructured":"Vecchiarelli-Federico LM, David Cervi D, Haeri M, Li Y, Nagy A, Ben-David Y, et al. Vascular Endothelial Growth Factor-A Positive and Negative Regulator of Tumor Growth. Cancer Res. 2010;70:863\u20137.","journal-title":"Cancer Res"},{"key":"2181_CR40","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrc2256","volume":"7","author":"JA Aguirre-Chiso","year":"2007","unstructured":"Aguirre-Chiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer. 2007;7:834\u201346.","journal-title":"Nat Rev Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2181-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T02:30:13Z","timestamp":1498271413000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2407\/16\/136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,22]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2181"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2181-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,22]]},"article-number":"136"}}